Carbamazepine, HLA-B*1502 and risk of Stevens––Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations

By Ferrell P Brent   McLeod Howard L  

Pharmacogenomics, Vol. 9, Iss. 10, 2008-10 ,pp. : 1543-1546

Future Medicine

Access to resources Recommend Favorite

External quality assessment for laboratory testing of HLA‐B*15:02 allele in relation to carbamazepine therapy

By  

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 32, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

HLA-B locus in Caucasian patients with carbamazepine hypersensitivity

By Alfirevic Ana   Jorgensen Andrea L   Williamson Paula R   Chadwick David W   Park B Kevin   Pirmohamed Munir  

Pharmacogenomics, Vol. 7, Iss. 6, 2006-09 ,pp. : 813-818

Future Medicine

Access to resources Recommend Favorite

Phenytoin safety questioned for HLA-B*1502-positive patients

By  

Inpharma, Vol. 1, Iss. 1666, 2008-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Cotrimoxazole: SJS/TEN overlap in an elderly liver transplant patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1424, 2012-01 ,pp. : 22-23

Adis International

Access to resources Recommend Favorite